Medtronic Reports Strong Q4 Sales, Hikes Dividend Despite Stock Drop
Medtronic reported strong Q4 2024 earnings with sales of $8.59 billion, surpassing expectations. The company saw broad-based organic revenue growth across all segments, particularly in neurology devices. Adjusted EPS was $1.46, slightly above consensus. Medtronic also increased its quarterly dividend to $0.70 per share and provided optimistic guidance for fiscal year 2025, forecasting adjusted EPS of $5.40-$5.50 and organic revenue growth of 4%-5%. Despite the positive results, MDT shares were down 2.64%.